These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8613376)

  • 1. Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.
    Lanar DE; Tine JA; de Taisne C; Seguin MC; Cox WI; Winslow JP; Ware LA; Kauffman EB; Gordon D; Ballou WR; Paoletti E; Sadoff JC
    Infect Immun; 1996 May; 64(5):1666-71. PubMed ID: 8613376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
    Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
    J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.
    Hutchings CL; Birkett AJ; Moore AC; Hill AV
    Infect Immun; 2007 Dec; 75(12):5819-26. PubMed ID: 17908809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei.
    Satchidanandam V; Zavala F; Moss B
    Mol Biochem Parasitol; 1991 Sep; 48(1):89-99. PubMed ID: 1779992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.
    Bauza K; Malinauskas T; Pfander C; Anar B; Jones EY; Billker O; Hill AV; Reyes-Sandoval A
    Infect Immun; 2014 Mar; 82(3):1277-86. PubMed ID: 24379295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-investigation of the circumsporozoite protein-based induction of sterile immunity against Plasmodium berghei infection.
    Reed RC; Louis-Wileman V; Wells RL; Verheul AF; Hunter RL; Lal AA
    Vaccine; 1996 Jun; 14(8):828-36. PubMed ID: 8817831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.
    Sedegah M; Jones TR; Kaur M; Hedstrom R; Hobart P; Tine JA; Hoffman SL
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7648-53. PubMed ID: 9636204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection.
    Nishikawa Y; Inoue N; Xuan X; Nagasawa H; Igarashi I; Fujisaki K; Otsuka H; Mikami T
    Vaccine; 2001 Jan; 19(11-12):1381-90. PubMed ID: 11163660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.
    González-Aseguinolaza G; Nakaya Y; Molano A; Dy E; Esteban M; Rodríguez D; Rodríguez JR; Palese P; García-Sastre A; Nussenzweig RS
    J Virol; 2003 Nov; 77(21):11859-66. PubMed ID: 14557672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium.
    Rodríguez D; González-Aseguinolaza G; Rodríguez JR; Vijayan A; Gherardi M; Rueda P; Casal JI; Esteban M
    PLoS One; 2012; 7(4):e34445. PubMed ID: 22529915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites.
    Leitner WW; Seguin MC; Ballou WR; Seitz JP; Schultz AM; Sheehy MJ; Lyon JA
    J Immunol; 1997 Dec; 159(12):6112-9. PubMed ID: 9550412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint.
    Porter MD; Nicki J; Pool CD; DeBot M; Illam RM; Brando C; Bozick B; De La Vega P; Angra D; Spaccapelo R; Crisanti A; Murphy JR; Bennett JW; Schwenk RJ; Ockenhouse CF; Dutta S
    Clin Vaccine Immunol; 2013 Jun; 20(6):803-10. PubMed ID: 23536694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
    Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
    J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
    Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein.
    Weiss R; Leitner WW; Scheiblhofer S; Chen D; Bernhaupt A; Mostböck S; Thalhamer J; Lyon JA
    Infect Immun; 2000 Oct; 68(10):5914-9. PubMed ID: 10992502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.
    Tartz S; Rüssmann H; Kamanova J; Sebo P; Sturm A; Heussler V; Fleischer B; Jacobs T
    Vaccine; 2008 Nov; 26(47):5935-43. PubMed ID: 18804138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.
    Li S; Rodrigues M; Rodriguez D; Rodriguez JR; Esteban M; Palese P; Nussenzweig RS; Zavala F
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5214-8. PubMed ID: 7685119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
    Reyes-Sandoval A; Sridhar S; Berthoud T; Moore AC; Harty JT; Gilbert SC; Gao G; Ertl HC; Wilson JC; Hill AV
    Eur J Immunol; 2008 Mar; 38(3):732-41. PubMed ID: 18266272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection.
    Scheiblhofer S; Chen D; Weiss R; Khan F; Mostböck S; Fegeding K; Leitner WW; Thalhamer J; Lyon JA
    Eur J Immunol; 2001 Mar; 31(3):692-8. PubMed ID: 11241272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.
    Oliveira-Ferreira J; Miyahira Y; Layton GT; Savage N; Esteban M; Rodriguez D; Rodriguez JR; Nussenzweig RS; Zavala F
    Vaccine; 2000 Mar; 18(17):1863-9. PubMed ID: 10699335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.